| ACE | Angiotensin converting enzyme |
| AKI | Acute kidney injury |
| AQP-2 | Aquaporin 2 |
| AV3V | Anteroventral third ventricle |
| BP | Blood pressure |
| CB | Carotid Body |
| CKD | Chronic kidney disease |
| DKA | Diabetic ketoacidosis |
| DM | Diabetes mellitus |
| DPP4 | Dipeptidyl peptidase-IV |
| ECM | Extracellular matrix |
| EPO | Erythropoietin |
| ESRD | End stage renal disease |
| GFR | Glomerular filtration rate |
| GLUT2 | Glucose transporter 2 |
| GLUT-9 | Glucose transporter 9 |
| HF | Heart failure |
| HIF | Hypoxia inducible factor |
| HOMA | Homeostasis model assessment |
| IML | Intermediolateral nucleus of spinal cord |
| IS | Indoxyl sulfate |
| NHE3 | Na+/H+ exchanger isoform 3 |
| NKCC-2 | Na-K-Cl cotransporter 2 |
| OVLT | Organum vasculosum laminae terminalis |
| PAC | Plasma aldosterone concentration |
| PAG | Periaqueductal gray |
| PCS | P-cresol sulfate |
| PRA | Plasma renin activity |
| PT | Proximal tubules |
| PVN | Paraventricular nucleus of hypothalamus |
| RAS | Renin-angiotensin system |
| RCT | Randomized clinical trials |
| ROS | Reactive oxygen species) |
| RVLM | Rostral ventrolateral medulla |
| SGLT-2 | Sodium–glucose cotransporter 2 |
| SGLT2i | Sodium–glucose cotransporter 2 inhibitor |
| SIRT-1 | Sirtulin-1 |
| SNA | Sympathetic nerve activity |
| SNS | Sympathetic nerve system |
| T1DM | Type 1 diabetes mellitus |
| T2DM | Type 2 diabetes mellitus |
| TGF | Tubular-glomerular feedback |
| TGFβ | Transforming growth factor β |
| TNFα | Tumor necrosis factor α |
| VEGF | Vascular endothelial growth factor |
| VHL-E3 | Von Hippel-Lindau ubiquitin ligase-E3 |
| URAT1 | Urate transporter 1 |